ÂÜÀòÂÒÂ×

Martin Stockley is currently the Director of CMC at Artios Pharma, a position they have held since 2024. Previously, they served as Associate Director, CMC at Artios from 2022 to 2024 and Principal Scientist and CMC Lead from 2017 to 2020. Martin has extensive experience as a medicinal chemist, having worked as Principal Scientist at MISSION Therapeutics and Cancer Research Technology from 2013 to 2017 and 2008 to 2013, respectively. They earned a PhD in Medicinal Chemistry from Newcastle University and completed a postdoctoral fellowship at the University of York.